Skip to main content
. 2022 Jun 15;23(12):6669. doi: 10.3390/ijms23126669

Table 4.

IC50 values [μM] and resistance factors (RF) for ovarian cancer cell lines and their resistant analogues (-cis), and lung cancer cell line A549 for compounds M1–6 *.

Compound SKOV3 SKOV3cis RF SKOV3 A2780 A2780cis RF A2780 A549
Ni1 5.8 (±0.6) 6.8 (±3.0) 1.2 3.5 (±0.3) 5.0 (±1.1) 1.4 5.4 (±0.1)
Ni2 36.6 (±9.3) 11.0 (±2.1) 0.3 7.7 (±2.0) 10.7 (±6.0) 1.4 5.2 (±1.0)
Ni3 7.1 (±3.7) 7.8 (±3.4) 1.1 8.0 (±4.8) 5.4 (±0.8) 0.7 3.8 (±0.0)
Ni4 9.2 (±5.1) 6.7 (±2.0) 0.7 3.8 (±0.1) 5.4 (±1.0) 1.4 7.7 (±2.2)
Ni5 10.3 (±5.0) 15.9 (±2.3) 1.5 10.4 (±0.8) 6.6 (±0.3) 0.6 8.1 (±3.9)
Ni6 8.6 (±4.6) 7.6 (±0.2) 0.9 8.8 (±8.1) 10.8 (±6.5) 1.2 9.7 (±6.3)
Pd1 13.7 (±8.2) 4.4 (±1.3) 0.3 3.1 (±0.0) 4.7 (±2.3) 1.5 2.8 (±1.2)
Pd2 5.8 (±4.1) 3.7 (±0.8) 0.6 3.1 (±0.6) 4.7 (±2.3) 1.5 8.7 (±8.2)
Pd3 3.8 (±1.0) 5.4 (±3.1) 1.4 3.1 (±0.0) 3.2 (±0.1) 1.0 4.5 (±1.7)
Pd4 5.7 (±2.5) 3.3 (±0.2) 0.6 3.1 (±0.0) 3.1 (±0.0) 1.0 6.3 (±2.4)
Pd5 12.9 (±7.1) 8.6 (±3.4) 0.7 4.3 (±0.5) 6.2 (±2.0) 1.4 9.8 (±1.3)
Pd6 8.9 (±1.0) 2.8 (±0.2) 0.3 12.7 (±1.0) 6.4 (±0.4) 0.5 2.4 (±0.4)
Pt1 6.6 (±2.1) 13.7 (±7.5) 2.1 3.4 (±0.0) 8.5 (±3.4) 2.5 4.2 (±0.7)
Pt2 28.2 (±7.3) 37.9 (±0.6) 1.3 50.9 (±15.4) 45.2 (±9.6) 0.9 7.4 (±2.5)
Pt3 38.7 (±5.1) 28.2 (±6.6) 0.7 16.8 (±18.9) 67.9 (±28.4) 4.0 43.0 (±2.9)
Pt4 7.7 (±0.6) 5.6 (±1.2) 0.7 5.4 (±3.0) 4.0 (±0.9) 0.7 4.8 (±1.3)
Pt5 12.0 (±7.2) 21.2 (±8.0) 1.8 4.7 (±1.0) 24.0 (±0.6) 5.1 8.0 (±0.8)
CDDP 3.8 (±2.8) 13.5 (±4.4) 3.6 1.3 (±0.2) 6.1 (±2.1) 4.7 (±2.6)

* IC50-values ≤ IC50-values CDDP or RF < 1 are marked in red.